Osterberger J, Lennon PA, Hu PC , Gu J, Hopwood VL, Glassman A
It bears no structural resemblance to THC, amphetamines, opioid alkaloids, cocaine metabolites, or any standard panel target
Without a structured plan, the psychological and physiological pressure to eat leads most people back to pre-treatment eating patterns, undoing months of progress and potentially triggering weight cyclinga pattern linked to metabolic dysfunction and future weight gain difficulty
Some patients reach their therapeutic dose at 1.7 mg, while others benefit from advancing to the maximum 2.4 mg dose, depending on weight loss goals and side effect tolerance